Allen Capital Group, LLC Gilead Sciences, Inc. Transaction History

Allen Capital Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$67.69 - $73.03 $203,543 - $219,601	-3,007 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $374,980 - $409,719	-5,908 Reduced 66.27%	3,007 $207,000
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $82,680 - $94,337	1,378 Added 18.28%	8,915 $576,000
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $110,354 - $125,743	-1,948 Reduced 20.54%	7,537 $439,000
Q3 2020 Oct 20, 2020	BUY	$62.1 - $78.08 $65,267 - $82,062	1,051 Added 12.46%	9,485 $599,000
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $610,115 - $708,456	8,434 New	8,434 $649,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Allen Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Allen Capital Group, LLC with notifications on news.